GTV, CTV and PTV — The Three Margins on Your Radiation Plan
Your radiation plan has three outlines nested around the same area, not one. GTV is the tumour that can be seen. CTV adds the tissue where microscopic cells are likely to be. PTV adds room for movement and daily positioning. That is why the treated area is bigger than the tumour on your scan — and every millimetre of it is a decision someone made and can explain.
Medically reviewed by Dr. Venkata Sushma P, Radiation Oncologist, MBBS · MD (Radiation Oncology) · Last reviewed August 2026
- Three questions, not three guesses — GTV answers what can be seen, CTV answers where disease is likely to be, PTV answers how exactly your position can be reproduced each day.
- The field is larger on purpose — Imaging has a resolution limit, so cells below it are invisible rather than absent — the CTV margin covers that, using published patterns of spread.
- Margin size is measured, not chosen — Cancer type, prior surgery, target movement, immobilisation and how often verification images are taken each move the number up or down.
- Delivered at an NABH-accredited partner centre — CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout.
on Panel
Survival Rate*
Treated
(800+ reviews)
What Are GTV, CTV and PTV?
GTV is the tumour your team can see on the scan. CTV is that tumour plus the surrounding tissue where microscopic cancer cells are likely to sit. PTV is the CTV plus a small safety margin for movement and daily positioning. Each volume contains the one before it, and they are drawn in that order, one inside the next.
If you have seen your plan on screen, you have seen three or four coloured outlines nested around the same area. Those outlines are not three opinions about where the tumour is. They are three different questions, answered one after the other.
The first question is what can we see? The second is where else is disease likely to be, even though we cannot see it? The third is how much does the target move, and how exactly can we reproduce your position every single day? Only the first of those is about the tumour itself. The other two are about uncertainty — and being explicit about uncertainty is what a radiotherapy plan is for.
| On your plan | Full name | What it contains | What defines its size |
|---|---|---|---|
| GTV | Gross Tumour Volume | Disease that can actually be seen or felt — on CT, MRI, PET-CT or clinical examination | What the imaging and the examination show |
| CTV | Clinical Target Volume | The GTV plus surrounding tissue where microscopic spread is considered likely | Known patterns of spread for that cancer type, and the anatomy around it |
| ITV | Internal Target Volume | The CTV plus the movement of the target itself, most often from breathing | A four-dimensional planning scan or a breathing assessment |
| PTV | Planning Target Volume | The CTV or ITV plus a geometric margin for day-to-day set-up variation | Immobilisation used, and how often verification images are taken |
| OARs | Organs at Risk | Healthy structures near the target that carry their own dose limits | Published dose constraints for each organ |
These are not house terms invented by one department. They are the international vocabulary of radiotherapy planning, and a radiation oncologist in Hyderabad, London or Tokyo means exactly the same thing by them.
Why Treat Beyond the Tumour If the Scan Shows Where It Is?
Because a scan shows only what is large enough to appear on it. Cancer cells can extend into nearby tissue in numbers too small for any current scan to detect. The CTV covers that likely microscopic extension. Treating only the visible tumour would leave those cells sitting just outside the treated area.
This is the part that unsettles people most: why are they radiating healthy tissue? The honest answer is that nobody can be certain the tissue immediately around a tumour is healthy. Imaging has a resolution limit. Below that limit, disease is invisible — not absent, invisible.
The CTV margin is not a nervous guess, though. It comes from decades of pathology: when tumours of a given type and stage are removed surgically and the specimen is examined under a microscope, it becomes clear how far cells typically travel from the visible edge, and in which direction. That evidence is what guideline bodies such as NCCN and ESMO turn into site-specific contouring guidance, and it is what your radiation oncologist applies when the CTV is drawn.
The margin is also shaped by anatomy, not just distance. Cancer cells spread along tissue planes and are held back by structures such as bone, fascia and the wall of an air cavity. So a CTV is rarely a neat circle around the GTV. It is expanded generously where spread is plausible and trimmed back at barriers where it is not.
The reframe: the treated area is bigger than the tumour because the plan is being honest about what a scan cannot see, and about how a body moves. A field drawn tightly around the visible tumour would look more precise on paper and cover less of the actual problem.
Did you know?
GTV, CTV and PTV are not local jargon. They were standardised internationally by the ICRU — the International Commission on Radiation Units and Measurements — in Report 50, published in 1993, and extended in Report 62 in 1999, which added the internal target volume and the planning organ-at-risk volume. That is why the same three letters appear on a radiotherapy plan anywhere in the world.
Why Is the Margin That Size and Not Bigger or Smaller?
Margin size is a measured compromise, not a round number. The CTV margin follows how that cancer type is known to spread. The PTV margin follows how accurately your position can be reproduced each day. A wider margin covers more uncertainty. It also places more healthy tissue inside the treated volume.
Six things move the number up or down. Every one of them is written into your own plan, and every one of them is a fair question to ask about.
Cancer Type and Site
Different cancers extend different distances from the visible edge, and in different directions. The CTV expansion follows site-specific contouring guidance, not one universal figure.
Whether Surgery Came First
After an operation the GTV may be gone entirely. The target then becomes the surgical bed and the tissue around it, guided by the operation notes and the pathology report.
How Much the Target Moves
A chest target can shift with every breath. A pelvic target moves with bladder and bowel filling. That movement is measured at planning and built into the ITV or the PTV.
Immobilisation
A moulded mask holds a head far more firmly than a headrest holds a shoulder. The steadier the position can be reproduced, the less geometric uncertainty the PTV has to absorb.
How Often Images Are Taken
Imaging you on the treatment couch before a sitting shows where the target actually is that day. More frequent verification narrows the set-up uncertainty the margin covers.
What Sits Next Door
Where the PTV brushes a structure with a strict dose limit, the plan has to negotiate. See organs at risk and dose constraints for how those limits are set.
None of these six is a preference. Each one is a source of uncertainty that has been measured and then converted into millimetres. That is the whole method: name the uncertainty, measure it, cover it, and keep everything else out of the high-dose region.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Understand Your Plan Before You Start It
You are allowed to ask what each outline covers, how many millimetres each expansion is, and which organs sit beside your target. Bring your reports and ask.
How Are the Three Margins Actually Drawn?
In a fixed order, over several days, before a single beam is switched on. Each outline is added on top of the last one. Nothing is expanded by eye. Every expansion is a numerical instruction typed into the planning system and then reviewed on screen, slice by slice.
Simulation scan
A planning CT is taken in the exact position you will hold for every sitting, with the immobilisation made or fitted first. Small reference marks are placed so the position can be found again.
Image fusion
Your diagnostic MRI or PET-CT is registered onto the planning CT, so the tumour can be outlined using the scan that shows it best while the geometry stays that of the planning scan.
The GTV is contoured
Your radiation oncologist outlines the visible disease on every slice it appears on. This is the only outline that traces something you can point to on an image.
The CTV is expanded
The GTV is grown by a site-specific distance to cover likely microscopic spread, then edited back wherever anatomy makes spread implausible — at bone, at fascia, at an air cavity wall.
ITV and PTV are added
Target movement is added first where it matters, then a geometric margin for daily set-up. This last expansion is uniform, because uncertainty in positioning has no preferred direction.
Organs at risk and optimisation
Nearby structures are outlined and their dose limits entered. The plan is then optimised to cover the PTV while holding each organ at risk below its constraint, and checked before approval.
Steps four and five are the ones patients almost never hear about, and they are the ones that explain the size of the field. Understanding why healthy tissue is included is easier once you also know why healthy tissue recovers but cancer cells do not.
What Is the Team Balancing When It Sets the Margin?
Two opposite risks. A margin that is too tight can leave part of the target outside the high-dose region on a day when your position shifts slightly. A margin that is too generous covers that risk but brings more normal tissue into the treated volume. The plan has to sit somewhere between the two.
| Consideration | A tighter margin | A more generous margin |
|---|---|---|
| Positional uncertainty covered | Less | More |
| Normal tissue inside the high-dose region | Less | More |
| Demand on daily set-up | High — needs firm immobilisation and frequent verification imaging | Lower — more tolerant of small day-to-day differences |
| Where it is typically used | Stable, well-immobilised targets with imaging before each sitting | Mobile targets, or where verification imaging is less frequent |
| What goes wrong if it is misjudged | Part of the target may sit outside full dose on some days | More healthy tissue receives dose than it needed to |
| Who decides | Your radiation oncologist and medical physicist, on your own plan — not a default setting | |
This is also why the field on your plan is not a fault to be corrected. It is a decision that has already been made deliberately, and it is explained further in why the treated area is larger than the tumour.
Can the Margin Be Made Smaller?
Part of it, sometimes. The other part, no. The PTV margin exists to absorb movement and set-up variation, so it responds to better immobilisation, breathing control and imaging before each sitting. The CTV margin reflects where microscopic disease is thought to sit. That is biology, and no imaging technology removes it.
This single distinction settles most of the confusion around margins. When you read that a newer technique “reduces the margin”, it is almost always the geometric PTV margin being discussed — the one that covers how well your position can be reproduced. Breath-hold techniques, four-dimensional planning, moulded immobilisation and verification imaging on the couch all act on that same uncertainty.
The CTV margin is untouched by any of it. You cannot image your way to certainty about cells that are, by definition, below the resolution of the scan. Its size is a clinical judgement based on the cancer type, the stage, the pathology and the anatomy — which is exactly why two people with the same diagnosis can be given different expansions. Some tumour types also behave differently once treatment starts, a separate issue covered in why some tumours do not respond well to radiation.
Where this happens: your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. If you want your own margins explained, ask your radiation oncologist to open the plan on screen and show you the GTV, the CTV and the PTV as three separate outlines.
What Should I Ask About the Margins on My Plan?
Five questions get you the actual numbers rather than reassurance. None of them needs a technical background, and every one has a specific answer already sitting inside your plan.
- Can you show me the GTV, CTV and PTV on screen? — seeing three nested outlines explains more in a minute than any description.
- How many millimetres is my CTV expansion, and why that figure? — ask which guidance it follows for my cancer type.
- How many millimetres is my PTV expansion? — and what immobilisation and verification imaging is that figure based on.
- Does my target move, and is there an ITV? — relevant mainly for chest, upper abdomen and some pelvic treatments.
- Which organs at risk sit inside or beside my PTV? — ask for them by name and for the dose each is held below.
Wanting to understand the plan rather than simply comply with it is a reasonable position, and a good radiation oncology team will meet it without treating the questions as a challenge.
Understanding the Plan Makes It Easier to Sit Through
Patients and families who wanted the planning logic explained, not just the appointment slot, on how the conversation went.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.GTV, CTV and PTV — Your Questions Answered
What is the difference between GTV, CTV and PTV?
GTV is the gross tumour volume — the disease that can actually be seen on a scan or felt on examination. CTV is the clinical target volume — the GTV plus the tissue around it where microscopic cancer cells are considered likely to sit. PTV is the planning target volume — the CTV plus a geometric margin that absorbs breathing movement and small day-to-day differences in how you are positioned. Each volume contains the one before it, and they are drawn in that order. The names are internationally standardised by the ICRU, so they mean the same thing in any radiotherapy department.
Why is the radiation treated area larger than the tumour on my scan?
Because a scan only shows disease that is large enough to appear on it. Cancer cells can extend into surrounding tissue in numbers far below what current CT, MRI or PET-CT can resolve. The CTV margin covers that likely microscopic extension, using published patterns of spread for that cancer type rather than a guess. A second, separate margin is then added for movement and set-up. So the larger field is a deliberate part of the planning logic, not a sign that the beam is imprecise.
How big is the PTV margin in radiotherapy?
It varies by treatment site and by centre, and it is commonly in the range of a few millimetres to around a centimetre. It is not a fixed number your team can quote from memory. The figure comes from how much the target itself moves, how firmly you are immobilised, and how often verification images are taken before a sitting. Your own plan states the exact expansion used for you. Ask your radiation oncologist to read it off the plan rather than relying on a general figure.
What is the ITV, and will it be on my plan?
The ITV, or internal target volume, is the CTV plus the movement of the target itself — most often movement caused by breathing. It was added to the international terminology in ICRU Report 62. You are most likely to see it on plans for the chest and upper abdomen, where a target can shift with every breath, and it is often measured with a four-dimensional planning scan or a breath-hold assessment. For sites that barely move, the plan may go straight from CTV to PTV without a separate ITV.
Can my PTV margin be made smaller?
Sometimes, and it depends on which uncertainty is being reduced. The PTV margin exists to absorb movement and set-up variation, so better immobilisation, breath-hold or breathing-controlled delivery, and imaging before each sitting all reduce the uncertainty that margin has to cover. The CTV margin is different. It reflects where microscopic disease is thought to sit, which is biology rather than geometry, so no imaging technology removes it. Any change to either margin is a decision for your radiation oncologist, made on your own plan.
Does a larger PTV mean more side effects?
A larger PTV places more normal tissue inside the high-dose region, and the tissue reactions associated with radiotherapy come from the normal tissue that receives dose. That is the trade-off your team is balancing when the margin is set. It is not a simple rule, though, because the organs at risk near your target each carry their own dose limits that the plan must respect regardless of the margin. Ask which structures sit inside or close to your PTV and what dose each one is being held below.